Neural Mechanisms of Decision Making in Hoarding Disorder
LOSS
1 other identifier
observational
25
1 country
1
Brief Summary
The purpose of this study is to understand the neural mechanisms of decision making in hoarding disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
April 3, 2018
CompletedStudy Start
First participant enrolled
July 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 30, 2026
July 16, 2025
July 1, 2025
7.9 years
March 27, 2018
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BOLD signal
BOLD signal derived from fMRI
up to 90 minutes
Study Arms (2)
Hoarding Disorder
Adults diagnosed with Hoarding Disorder
Healthy Controls
Adults without mental illness
Interventions
Functional magnetic resonance imaging or fMRI measures brain activity by detecting changes in blood flow. Participants will do cognitive tasks during fMRI.
Eligibility Criteria
Individuals with Hoarding Disorder and Healthy Participants
You may qualify if:
- ages 18-70
- primary diagnosis of hoarding disorder
- sufficient severity of hoarding symptoms
- stable on psychotropic medications for 1 month prior to study enrollment
- capacity to provide informed consent
- ability to tolerate clinical study procedures
- ages 18-70
- capacity to provide informed consent
You may not qualify if:
- psychiatric or medical conditions that make participation unsafe
- pregnant or nursing females
- concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)
- presence of metallic device or dental braces
- any current or lifetime psychiatric diagnosis
- current or past use of psychotropic medication
- pregnant or nursing females
- major medical or neurological problem
- presence of metallic device or dental braces
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University
Stanford, California, 94305, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 27, 2018
First Posted
April 3, 2018
Study Start
July 8, 2018
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
May 30, 2026
Last Updated
July 16, 2025
Record last verified: 2025-07